Clinical trial
Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine
NCT00271479 · Epicentre, Other · Completed
Key facts
| NCT number | NCT00271479 |
|---|---|
| Title | Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine |
| Official title | Assay of the Immunogenicity of Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine in Africa |
| Lead sponsor | Epicentre, Other |
| Collaborators | Norwegian Institute of Public Health University of Oslo Medecins Sans Frontieres, Netherlands |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal, Meningitis, Meningococcic |
| Intervention type | Biological |
| Interventions | A, C, Y, W135 meningococcal polysaccharide vaccine |
| Enrollment | 720 |
| Start date | Jun 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Jan 2, 2006 |
| Last update posted | Dec 22, 2006 |
| Countries | Norway, Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: